维普期刊资源整合服务平台（V6.5）

55篇 您的检索式：作者名="SERVE H"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Role of receptor tyrosine kinases in gastric cancer: New targets for a selective therapy显示文摘受体酷氨酸家族 ases (RTK ) 象表皮的生长因素受体家庭那样包括增长和变形传播参予肿瘤形成的几步。几已知的 RTK 起来在是主要的胃的癌症调整了定制的治疗的目标。仅仅初步的数据然而,在使用上存在当前临床上可得到的药象在胃的癌症的背景的 trastuzumab, cetuximab, bevacizumab, gefitinib, erlotinib,和 imatinib 那样。现出症状之前的潜的数据建议他们的使用的一个潜在的好处,特别在有“常规”的抑制细胞的联合治疗。这评论象新途径和药一样在癌症治疗关于他们的使用总结当前的知识优化治疗成功。	JC Becker C Müller-Tidow H Serve W Domschke T Pohle	2006	World Journal of Gastroenterology2006，12，21：	19
2	Case of Aeromonas veronii( DNA Group 10 ) bacteremia 显示文摘	ABBOTT S L SERVE H JANDA J M	1994	J Clin Microbiol1994，32，12：	1
3	E-and A-type cyelins as markers for cancer diagnosis and prognosis 显示文摘	Yasmeen A Berdel WE Serve H	2003	Expert Rev Mol Diagn2003，3，5：	1
4	A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia ( AML ) or not amenable to conventional therapy for the disease显示文摘	Fiedler W Serve H Dohenr H	2005	Blood2005，105，3：	1
5	A phase I study of SUI1248 in the treatment of patients with refractory or resistant acute myeloid leukemia(AMI)or not amenable to conventional therapy for the disease显示文摘	Fiedler W Serve H Dohner H	2005	Blood2005，105，：	1
6	E-and A-type eye- lins as markers for cancer diagnosis and prognosis 显示文摘	Yasmeen A Berdel W E Serve H	2003	Ex- pert Rev Mol Diagn2003，3，61：	1
7	Ubiquitination and selective autophagy显示文摘	Shaid S Brandts CH Serve H	2013	Cell Death Differ2013，20，：	1
8	A phase Ⅰ study of SU11248 in tile treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease 显示文摘	Fiedler W Serve H Dohner H	2005	Blood2005，105，3：	1
9	E-and A-type cyclins as markers for cancer diagnosis and prognosis 显示文摘	Yasmeen A Berdel W E Serve H	2003	ExpertRevMolDiagn2003，3，5：	1
10	A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease 显示文摘	FIEDLER W SERVE H DOHNER H	2005	Blood2005，105，3：	1
11	Efficient modeling of nonconventional wells with downholeinflow control devices显示文摘	VALVATNE P H SERVE J DURLOFSKY L J	2003	Journal of Petroleum Scienceand Engineering2003，39，1：	1
12	Efficient modeling of nonconventional wells with down hole inflow control device 显示文摘	Valbatne P H Serve J Durlofsky L J	2003	Journal of Petroleum Science and Engineering2003，39，2：	1
13	Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo- controlled trial 显示文摘	Serve H Krug U Wagner R	2013	J Clin Oncol2013，31，25：	1
14	A phase I study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leu- kemia (AML) or not amenable to conventional therapy for the disease 显示文摘	Fiedler W Serve H Dohner H	2005	Blood2005，105，3：	1
15	A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease显示文摘	FIEDLER W SERVE H DONER H	2005	Blood2005，105，3：	1
16	A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease 显示文摘	FIEDLER W SERVE H DOHNER H	2005	Blood2005，105，3：	1
17	A phase I study of SU1248 in the treatment of patients with refractory of resistant acute myelold leukemia (AML) or not amenable to conventional therapy for the disease显示文摘	Fiedler W Serve H Dohner H	2005	Blood2005，105，3：	1
18	Ubiquitination and selective autophagy显示文摘	Shaid S Brandts CH Serve H	2013	Cell Death Differ2013，20，1：	1
19	A phase Ⅰ study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease显示文摘	Fiedler W Serve H Dohner H	2005	Blood2005，105，3：	1
20	Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin- 1 显示文摘	Oelmann E Kraemer A Serve H	1997	Int J Cancer1997，71，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示